Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Educational Program in PCOS
NCT07811856Phase 4Completed
- Sponsor
- Jerash University
- Start
- Aug 2026
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of liquid metformin (Aspargo Labs) in polycystic ovary syndrome (PCOS) (3 arms), sponsored by Jerash University. Primary endpoints: Body Mass Index at 6 months, Serum Insulin at 6 months and 22 more. Started Aug 2026; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT07811856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07811856.